No article text was recorded for this version.
multi-modal immune response assessment
Version 1 of 119 papers20 conceptsfrozen 2026-10-04
Papers in this version
- Blog: GEM-PA-Based Subunit Vaccines of Crimean Congo Hemorrhagic Fever Induces Systemic Immune Responses in Mice
- Blog: WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
- Blog: Evaluation of <i>Leishmania</i> homolog of activated C kinase (LACK) of <i>Leishmania donovani</i> in comparison to glycoprotein 63 as a vaccine candidate against visceral leishmaniasis
- Blog: Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Scarification vaccination
- Blog: Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
- Blog: A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
- Blog: Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
- Blog: Immunogenicity and Protective Efficacy of a Recombinant Toxoplasma gondii GRA12 Vaccine in Domestic Cats
- Blog: Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
- Blog: Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial
- Blog: Substratum interactions determine immune response to allogeneic transplants of endothelial cells
- Blog: The Anti-mutated Citrullinated Vimentin Response Classifies Patients with Rheumatoid Arthritis into Broad and Narrow Responders
- Blog: Development and Characterization of a Recombinant galT-galU Protein for Broad-Spectrum Immunoprotection Against Porcine Contagious Pleuropneumonia
- Blog: Protective immunity against Trichinella spiralis infection induced by TsNd vaccine in mice
- Blog: Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates
- Blog: Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
- Blog: Generation and immunogenicity analysis of recombinant classical swine fever virus glycoprotein E2 and Erns expressed in baculovirus expression system
- Blog: Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice
- Blog: Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
History & citation
Current · Permanent link
- This direction split from longitudinal immunity tracking (53% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_multi_modal_immune_response_assessment_80491aae,
title = {multi-modal immune response assessment},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/multi-modal-immune-response-assessment/rdr_80491aae665a477b910e5adc903a7444},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_multi_modal_immune_response_assessment_80491aae_v1,
title = {multi-modal immune response assessment},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/multi-modal-immune-response-assessment/rdr_80491aae665a477b910e5adc903a7444/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}